Clinical Trial Update: 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of 3-AP (Triapine) with radiation therapy in patients with unresectable stage III pancreatic cancer; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• 3-AP (Triapine) (3-aminopyridine-2-carboxaldehyde thiosemicarbazone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 | Phase 1 | Status: COMPLETED